Ftse Mib
33.838,43
0,27%
DAX
17.965,91
0,25%
S&P 500
5.032,66
0,28%
NASDAQ Composite
15.752,11
0,94%
Bitcoin
58.309,36
0,12%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Merus NV (MRUS) Merus NV (MRUS) Notizie

Merus NV

MRUS
47,475
0,455 (0,97%)
Ultimo aggiornamento: 15:34:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/4/202418:00GLOBEMerus Presents Preclinical Data Demonstrating Efficacy of..
03/4/202414:00GLOBEMerus to Participate in a Fireside Chat at the 23rd Annual..
06/3/202414:15EDGAR2Form 8-K - Current report
06/3/202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202422:30GLOBEMerus Announces Publication of an Abstract for Presentation..
04/3/202414:00GLOBEMerus to Participate in a Fireside Chat at the Leerink..
28/2/202422:55EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202422:15GLOBEMerus Announces Financial Results for the Fourth Quarter and..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00GLOBEMerus to Participate in Upcoming Investor Conferences
20/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:29EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202302:40GLOBEMerus Presents Interim Data on MCLA-129 at ESMO Asia..
01/12/202316:47EDGAR2Form 144 - Report of proposed sale of securities
26/11/202317:05GLOBEMerus Announces Publication of Abstracts on MCLA-129 for..
02/11/202321:12GLOBEMerus Announces Financial Results for the Third Quarter 2023..
02/11/202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202313:00GLOBEMerus to Participate in Upcoming Investor Conferences
23/10/202313:30GLOBEMerus’ Zeno Interim Data Continues to Demonstrate Robust and..
16/10/202301:58GLOBEMerus Announces Business Update Conference Call
11/10/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202315:32GLOBEMerus Announces Abstracts Accepted for Presentation at the..
31/8/202314:00GLOBEMerus to Participate in Upcoming Investor Conferences
11/8/202322:01EDGAR2Form 8-K - Current report
11/8/202315:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/8/202303:53GLOBEMerus Announces Pricing of Public Offering of Common Shares
09/8/202322:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202322:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
07/8/202322:26GLOBEMerus Announces Financial Results for the Second Quarter..
07/8/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/7/202314:00GLOBEMerus Announces Two Clinical Abstracts on Zenocutuzumab..
05/7/202322:01GLOBEZenocutuzumab (Zeno) granted second Breakthrough Therapy..
29/6/202322:30GLOBEZenocutuzumab (Zeno) granted Breakthrough Therapy..
15/6/202313:47GLOBEMerus Appoints Life Sciences Strategic and Financial..
31/5/202314:00GLOBEMerus to Participate in a Fireside Chat at the Jefferies..
04/5/202322:25GLOBEMerus Announces Financial Results for the First Quarter 2023..
Apertura: 47,67 Min: 47,4138 Max: 47,83
Chiusura: 47,02

La tua Cronologia

NASDAQ
MRUS
Merus NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network